关于 Kite Pharma, Inc.
Kite Pharma, Inc. is an American biotechnology company that develops cancer immunotherapy products with a primary focus on genetically engineered autologous CAR T cell therapy - a cell-based therapy which relies on chimeric antigen receptors and T cells. Founded in 2009, and based in Santa Monica, California, it was acquired by Gilead Sciences in 2017.
Source: Wikipedia
行业Biotechnology
总部Santa Monica, CA
成立2009
法律形式C Corporation
状态营业中
专利863 项专利
GPC3 BINDING MOLECULESUS20260242507A1 · 2026
Methods of administering chimeric antigen receptor immunotherapyUS12709639B2 · 2026
关键数据
法律信息
| 法定名称 | Kite Pharma, Inc. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1510580在 SEC EDGAR 上查看 ↗ |
| 注册地址 | Santa Monica, CA |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Nov. 14, 2026